Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 28

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 28
---
 are no agreements or arrangements under which the Company or any of its Subsidiaries
is obligated to register the sale of any of their securities under the Securities Act (except the Registration Rights Agreement), (v)
there are no outstanding securities or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions,
and there are no contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become
bound to redeem a security of the Company or any of its Subsidiaries, (vi) there are no securities or instruments containing anti-dilution
or similar provisions that will be triggered by the issuance of the Securities as described in this Agreement and (vii) the Company does
not have any share appreciation rights or “phantom share” plans or agreements or any similar plan or agreement. The Company
has furnished or made available (provided that any documents filed with the SEC and available on the SEC’s EDGAR system shall be
deemed to have been made available) to the Investor true and correct copies of the Company’s Articles of Association, as in effect
on the Execution Date (the “”), and summaries of the material terms of all securities convertible
into or exercisable for Ordinary Shares (including Ordinary Shares represented by Depositary Shares), if any, and copies of any documents
containing the material rights of the holders thereof in respect thereto that are not disclosed in the SEC Documents.

| -13- |

(d) . Upon the allotment and payment therefor in accordance with the terms and conditions of this Agreement, the Purchase
Shares shall be validly issued, fully paid and nonassessable and free from all taxes, liens, charges, restrictions, rights of first refusal
and preemptive rights with respect to the issue thereof imposed by the Company, with the holders being entitled to all rights accorded
to a holder of Depositary Shares. Upon the allotment in accordance with the terms and conditions of this Agreement, the Commitment Shares
(as defined in ), if any, shall be validly issued, fully paid and nonassessable and free from all taxes, liens, charges,
restrictions, rights of first refusal and preemptive rights with respect to the issue thereof imposed by the Company, with the holders
being entitled to all rights accorded to a holder of Depositary Shares.

(e) . The execution, delivery and performance of the Transaction Documents by the Company and the consummation